Moreover, by determination of plasma CA IX values using an enzyme-linked immunosorbent assay (ELISA) we evaluated the concentration of soluble CA IX (s-CA IX) in plasma samples from AAA patients suggesting the presence of s-CA IX in hypoxia-related cardiovascular diseases. The gene discussed is CA9; the disease is triple-A syndrome.